日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A Phase II Open-Label, Randomized Clinical Trial of Atezolizumab with or without Human Recombinant IL-7 (CYT107) in Advanced Urothelial Cancer

一项评估阿特珠单抗联合或不联合人重组IL-7(CYT107)治疗晚期尿路上皮癌的II期开放标签、随机临床试验

Randy F Sweis ,Gurkamal S Chatta ,Rohit K Jain ,Helen Moon ,Scott Edward Delacroix ,Alana Fang ,Leonard D'Amico ,Angela Shaulov Kask ,Martin A Cheever ,Steven Fling ,Elad Sharon ,Andreanne Lacroix ,Judith C Kaiser ,Russell K Pachynski ,Evan Y Yu

Broad neutralization coverage of HIV by multiple highly potent antibodies

多种高效抗体对 HIV 具有广泛的中和覆盖范围

Laura M Walker, Michael Huber, Katie J Doores, Emilia Falkowska, Robert Pejchal, Jean-Philippe Julien, Sheng-Kai Wang, Alejandra Ramos, Po-Ying Chan-Hui, Matthew Moyle, Jennifer L Mitcham, Phillip W Hammond, Ole A Olsen, Pham Phung, Steven Fling, Chi-Huey Wong, Sanjay Phogat, Terri Wrin, Melissa D S